How Vitamin B1 (Thiamine) Interacts with Weight-Loss Medications
Generally safe · The honest verdict
No major interaction expected
Thiamine (vitamin B1) has no documented interaction with semaglutide or tirzepatide and is generally safe to take alongside GLP-1 medications; the clinically important angle is that severe thiamine deficiency (Wernicke's encephalopathy) has been reported in patients with extreme GLP-1-related vomiting and drastically reduced intake.
Vitamin B1, or thiamine, is a water-soluble B vitamin that plays a critical role in converting food into energy. For most people taking GLP-1 medications like semaglutide or tirzepatide, taking a standard thiamine supplement is safe and poses no risk of drug interaction. However, a small number of case reports have linked weeks of severe, persistent vomiting on these medications to a dangerous depletion of thiamine stores, which can lead to a neurological emergency called Wernicke's encephalopathy. This page explains why thiamine is generally safe, the specific mechanism behind this rare but serious risk, and exactly what to watch for.
This is general nutrition and wellness information, not medical advice. If you're on a weight-loss medication or managing a health condition, confirm specifics with your clinician.
Why they interact
Here's what actually happens when Vitamin B1 Thiamine meets No pharmacokinetic interaction with GLP-1 drugs; no blood-sugar, CYP, or absorption mechanism identified — in plain language.
Thiamine is a water-soluble B vitamin that serves as a coenzyme in carbohydrate metabolism (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase). GLP-1 drugs are cleared by peptide cleavage, not CYP450 enzymes; thiamine has no established effect on any of these clearance pathways. Thiamine does not affect blood glucose, does not cause GI distress at standard doses, and is not a CYP inhibitor or inducer. At supplemental doses (up to 100 mg), excess is excreted in urine with no toxicity reported; no established UL. The clinically important nuance that separates thiamine from other 'no data / generally safe' vitamins is a small but serious body of case reports linking prolonged severe vomiting on GLP-1 drugs to thiamine deficiency and Wernicke's encephalopathy — a neurological emergency. When a GLP-1 user has weeks of intractable vomiting and barely eats, thiamine stores (which last only 14–18 days without dietary replenishment) can be exhausted. This is not an interaction between thiamine and the GLP-1 drug; it is a consequence of extreme caloric and nutritional restriction from GLP-1-induced vomiting. The practical implication: thiamine supplementation during extended severe vomiting episodes is a sensible protective measure, and pages should address this forthrightly.
What the research says
No direct GLP-1 + thiamine co-administration studies found. Evidence level: no data for direct interaction. Case reports of Wernicke's encephalopathy on GLP-1 drugs: multiple case series published 2023–2024.
When and how to take it
No GLP-1-specific timing adjustment; take as directed. If experiencing prolonged severe vomiting on a GLP-1 drug (days, not hours), discuss thiamine supplementation or IV replacement with your prescriber rather than waiting.
Signs to watch for
- Prolonged vomiting lasting more than a few days on a GLP-1 — the trigger for thiamine concern
- Eye movement problems, confusion, unsteady gait — early signs of Wernicke's encephalopathy (a medical emergency; seek care immediately)
- Generalized fatigue, numbness/tingling (early thiamine deficiency symptoms, non-specific)
What to do about it
Practical, non-prescriptive steps — the specifics still belong to you and your clinician.
For most users: A standard multivitamin covering 100% DV of thiamine is sufficient insurance during GLP-1 treatment.
If vomiting persists beyond 2-3 days: Contact your prescriber. Do not wait weeks. Ask specifically about thiamine status and whether oral or IV supplementation is warranted.
If neurological symptoms appear (eye movement changes, confusion, gait problems): Seek emergency care immediately. Wernicke's encephalopathy is reversible if treated promptly with high-dose IV thiamine, but delays can lead to permanent damage.
Why Thiamine Is Different from Other 'Safe' Supplements on a GLP-1
Most water-soluble vitamins have a genuinely boring interaction story with GLP-1 drugs — and that's a good thing. Riboflavin, B12 at usual doses, and biotin all pass through the body without touching the peptide-cleavage pathways that clear semaglutide or tirzepatide. Thiamine shares that clean pharmacokinetic profile, but it earns a more careful discussion for one reason: your body's thiamine reserves are remarkably small and turn over fast.
The human body stores only about 25 to 30 mg of thiamine, concentrated in skeletal muscle, heart, liver, and brain. Without regular dietary replenishment, those stores can be functionally exhausted in just 14 to 18 days. Thiamine is also the gatekeeper coenzyme for carbohydrate metabolism — it's required by pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase to turn glucose into ATP. When someone on a GLP-1 medication experiences weeks of severe vomiting and eats almost nothing, two things happen simultaneously: thiamine intake drops to near zero, and the body's demand for thiamine doesn't stop because glucose metabolism continues.
This is not a drug interaction. It's a nutritional depletion scenario that happens to be triggered by a drug's side effect. That distinction matters because it changes the clinical response: you don't stop the GLP-1 medication because of a thiamine concern; you manage the vomiting and supplement the thiamine. But you have to know the scenario exists to respond to it, and that's what separates thiamine from its safer-seeming B-vitamin siblings.
Bottom line
Thiamine is generally safe and no pharmacokinetic interaction exists, but the severe-vomiting depletion risk earns it a more nuanced discussion than riboflavin or B12.
The Wernicke's Encephalopathy Cases: What Happened and Why
In 2023 and 2024, multiple case series documented a pattern that caught the attention of endocrinologists and emergency physicians: patients on GLP-1 receptor agonists presenting with the classic triad of Wernicke's encephalopathy — eye movement abnormalities (nystagmus or ophthalmoplegia), ataxia (unsteady gait), and confusion. The common thread in every case was weeks of intractable vomiting leading to drastically reduced food intake.
Wernicke's encephalopathy is a neurological emergency caused by severe thiamine deficiency. It's historically associated with chronic alcoholism, but the mechanism is the same regardless of the trigger: thiamine-dependent enzymes in the brain can't function, leading to neuronal damage in the thalamus, mammillary bodies, and periaqueductal gray matter. The condition is reversible if caught early and treated with high-dose intravenous thiamine. Missed or delayed, it can progress to Korsakoff syndrome — permanent memory impairment and confabulation.
The GLP-1 cases followed a consistent script. A patient titrated up on semaglutide or tirzepatide, developed nausea that progressed to daily vomiting, and over the course of three to six weeks, oral intake dropped to near nothing. Thiamine stores, with no dietary replenishment, were depleted. The neurological symptoms appeared gradually — often dismissed initially as dehydration or medication side effects — until the full triad emerged. Importantly, none of these cases involved a pharmacokinetic interaction between thiamine and the GLP-1 drug. The drug caused the vomiting; the vomiting caused the deficiency.
These cases are rare. Millions of people take GLP-1 medications, and the number of reported Wernicke's cases is small. But the severity of the outcome — permanent brain damage if untreated — means the risk deserves a place in every discussion about managing GLP-1 side effects. The solution is straightforward: recognize prolonged vomiting as a thiamine-depletion risk and act before neurological symptoms appear.
Bottom line
The cases are not caused by an interaction between thiamine and the GLP-1 drug; they are caused by weeks of severe vomiting preventing normal thiamine intake — the solution is managing the vomiting and supplementing thiamine during extended episodes.
Normal Thiamine Needs and GLP-1 Caloric Restriction
The Recommended Dietary Allowance (RDA) for thiamine is modest: 1.1 mg per day for adult women and 1.2 mg per day for adult men. Pregnancy and lactation push that slightly higher, to 1.4 mg. These amounts are easily obtained from a normal diet — a 3-ounce serving of pork chop provides about 0.7 mg, a cup of fortified breakfast cereal can deliver 0.5 to 1.5 mg, and black beans, sunflower seeds, and whole wheat bread each contribute meaningful amounts.
GLP-1 medications change the math, but not dramatically for most people. The appetite suppression and delayed gastric emptying these drugs produce typically reduce daily caloric intake by 500 to 800 calories during the active weight-loss phase. That reduction can shrink the margin for micronutrient adequacy, especially if food choices narrow to smaller portions of the same limited set of foods. A person who previously got thiamine from a varied diet might, on a GLP-1, eat half a sandwich and a piece of fruit for lunch and call it done — and that half-sandwich might not carry the thiamine the full sandwich did.
The fix is simple and doesn't require a separate thiamine supplement. A standard multivitamin covering 100% of the Daily Value for thiamine (1.2 mg) closes any gap created by reduced food intake. This is a reasonable baseline safeguard for anyone on a GLP-1 medication, not because the drug depletes thiamine but because eating less food means fewer opportunities to hit micronutrient targets. The edge case — the one that demands a different response — is not typical appetite reduction. It's prolonged vomiting.
Bottom line
Baseline thiamine sufficiency is easy to maintain with a multivitamin during GLP-1-driven caloric restriction; the edge case to watch is prolonged vomiting, not typical dose-related reduced appetite.
How GLP-1 Drugs Are Cleared — Confirming Thiamine Doesn't Interfere
If you're the kind of person who wants to know why thiamine is safe rather than just being told it's safe, this section is for you. GLP-1 receptor agonists like semaglutide and tirzepatide are peptide-based drugs. They're not metabolized by the liver's CYP450 enzyme system — the pathway responsible for processing many oral medications and the source of most drug-drug interactions. Instead, GLP-1 drugs are cleared through proteolytic cleavage by enzymes like dipeptidyl peptidase-IV (DPP-IV) and neutral endopeptidases, followed by renal elimination of the breakdown products.
Thiamine doesn't touch any of this. It's not a CYP450 inhibitor or inducer. It doesn't compete for DPP-IV binding. It doesn't alter gastric pH in a way that would affect subcutaneous drug absorption. At supplemental doses up to 100 mg — far above the RDA — thiamine absorption in the small intestine shifts from an active transport mechanism to passive diffusion, and any excess beyond what tissues can use is rapidly excreted unchanged in urine. There is no established Tolerable Upper Intake Level (UL) for thiamine because no toxicity has been demonstrated at any oral dose studied.
This is the pharmacist-level reassurance: your B-complex vitamin is not interfering with your weekly injection. The two substances coexist in the body without meaningful interaction. The clinical concern with thiamine and GLP-1s is not pharmacokinetic — it's nutritional, and it only arises in the specific context of prolonged, severe vomiting.
Bottom line
No interaction; this section exists specifically to put the 'zero pharmacokinetic interference' finding on record so readers are reassured, not just told 'generally safe.'
Practical Guidance: Thiamine During GLP-1 Treatment
For the vast majority of people taking semaglutide, tirzepatide, or any other GLP-1 receptor agonist, the thiamine playbook is short. Take a standard multivitamin or B-complex that provides at least 100% of the Daily Value for thiamine. That's it. You don't need a separate high-dose thiamine supplement, and you don't need to time your B vitamins around your injection day.
The playbook changes if vomiting enters the picture — and the threshold for action is lower than most people assume. Nausea is common on GLP-1 drugs, especially during dose titration. But vomiting that persists beyond two or three days, or vomiting that prevents you from keeping down meals and fluids, is a different category. At that point, thiamine stores are not yet depleted — you have a couple of weeks of buffer — but the clock is ticking. Contact your prescriber. The conversation should cover managing the vomiting (dose adjustment, antiemetics, hydration) and whether oral thiamine supplementation or, in severe cases, IV thiamine replacement is appropriate.
It's worth briefly distinguishing thiamine from two other B vitamins that come up in GLP-1 conversations. Vitamin B6 (pyridoxine) is sometimes used at 10 to 25 mg for nausea relief — it has an evidence base for pregnancy-related nausea and is sometimes tried for GLP-1 nausea, but high doses above 100 mg per day carry a risk of peripheral neuropathy. Vitamin B12 is a separate concern for people taking metformin alongside their GLP-1, since metformin can reduce B12 absorption over time and warrants periodic monitoring. Thiamine's story is distinct: no nausea-relief role, no neuropathy risk at high doses, and a specific, rare, but serious depletion scenario tied to prolonged vomiting.
Bottom line
Most GLP-1 users need no special thiamine action; the action item is having a clear protocol for prolonged vomiting episodes before they happen.
What most pages leave out
Several health articles imply thiamine 'boosts metabolism' on a GLP-1 program; this is not supported by evidence — thiamine is a coenzyme needed for normal carbohydrate metabolism, not an accelerant. Honest pages clarify the Wernicke's risk without overstating it as common.
We flag this so you can make an informed choice — not to scare you off.
❓Frequently Asked Questions
Yes, you can take vitamin B1 (thiamine) with Ozempic. There is no documented interaction between thiamine and semaglutide at any standard dose. Thiamine is a water-soluble vitamin, and any excess your body doesn't need is excreted in urine.
No pharmacokinetic interaction exists between thiamine and semaglutide. Semaglutide is cleared from the body through peptide cleavage by enzymes like DPP-IV, not through the CYP450 liver pathways that thiamine would need to affect to cause an interaction. The two substances coexist without interfering with each other.
Thiamine depletion is a risk only during prolonged severe vomiting lasting days to weeks on a GLP-1 medication. Standard caloric restriction from appetite suppression alone is unlikely to cause deficiency, especially if you take a multivitamin covering 100% of the Daily Value for thiamine. The risk arises when vomiting prevents you from keeping down food and supplements for an extended period.
Yes, vitamin B1 is generally safe to take with tirzepatide (Zepbound, Mounjaro). No documented interaction exists, and the same guidance applies as with semaglutide. The safety concern is not about a direct drug interaction but about the rare scenario of thiamine depletion from prolonged, severe vomiting.
Wernicke's encephalopathy is a rare but serious neurological emergency caused by severe thiamine deficiency. A small number of case reports have documented it in GLP-1 users who experienced weeks of intractable vomiting with minimal food intake. Symptoms include eye movement abnormalities, confusion, and unsteady gait. It requires immediate emergency care and high-dose IV thiamine; delays in treatment can lead to permanent brain damage.
Choose a multivitamin that covers 100% of the Daily Value for thiamine (1.2 mg) and other B vitamins. There is no thiamine-specific requirement beyond the standard RDA unless you have experienced prolonged vomiting. A standard, reputable multivitamin is sufficient for nutritional insurance during GLP-1 treatment.
Thiamine itself is not an antiemetic and has no established role in treating nausea. Vitamin B6 (pyridoxine) is the B vitamin with evidence for nausea relief, particularly in pregnancy. Thiamine's relevance during GLP-1 treatment is nutritional insurance against deficiency if vomiting occurs, not treating the nausea itself.
The body's thiamine stores are limited to about 25 to 30 mg and can be functionally depleted in 14 to 18 days without adequate dietary intake. This short window is why prolonged vomiting on a GLP-1 medication — where both food and supplement intake may drop to near zero — warrants attention before neurological symptoms develop.
Medically reviewed by
Chet Tharpe, MDBoard-certified physician
Last reviewed July 2026
Related Articles
How Does Vitamin B Complex Interact with Weight-Loss Medications?
Vitamin B complex has no direct interaction with semaglutide or tirzepatide, but metformin co-therapy, high-dose B6, and biotin lab interference are real concerns. Learn what matters.
Read moreHow Does Vitamin B9 (Folate) Interact with Weight-Loss Medications?
Folate has no direct interaction with GLP-1s, but reduced food intake can cause shortfalls, and high-dose folic acid can mask a dangerous B12 deficiency. Here's the safe strategy.
Read moreHow Vitamin B5 (Pantothenic Acid) Interacts With Weight-Loss Medications
Pantothenic acid (B5) has no direct interaction with semaglutide or tirzepatide, but high-dose acne regimens can worsen GLP-1 GI side effects. Evidence-based safety guide.
Read moreHow Vitamin B6 Interacts With Weight-Loss Medications
Low-dose B6 may ease GLP-1 nausea, but chronic high doses risk permanent neuropathy. Learn safe limits, hidden supplement sources, and what to watch for.
Read moreHow Does Vitamin A Interact with Weight Loss Medications?
Vitamin A has no direct interaction with GLP-1s, but stacking supplements can push you past the safe upper limit. Learn the crucial difference between retinol and beta-carotene.
Read moreHow Vitamin C Interacts With Weight Loss Medications
Vitamin C has no direct interaction with semaglutide or tirzepatide. Learn the real risk of high-dose diarrhea and the surprising iron-absorption benefit for GLP-1 users.
Read moreOn a GLP-1, or thinking about one?
If you take Vitamin B1 Thiamine alongside a GLP-1, it helps to have your medication managed by a clinician who sees the whole picture.Curex connects you with licensed clinicians for compounded GLP-1 medications, if it's right for you.
- Compounded semaglutide from $49/mo, tirzepatide from $149/mo
- Prescribed by licensed clinicians after an online visit
- Delivered to your door — no in-person clinic required
Important: This page is general information, not medical advice, and it does not account for your health or medications. Supplements can interact with prescription drugs in ways that depend on your dose and situation. Curex offers compounded GLP-1 medications through licensed clinicians — compounded medications are not FDA-approved, and the FDA has not evaluated their safety or efficacy. The supplement discussed here is not a Curex product. Always talk to your pharmacist or prescriber before combining a supplement with any weight-loss medication.
This content is for general informational purposes only and is not medical or nutritional advice, a diagnosis, or a substitute for professional judgment. It does not account for your health, medications, or goals, and nutrition information changes over time. Always talk with a qualified clinician or dietitian before making significant changes to your diet, supplements, or medications. Curex offers compounded GLP-1 medications through licensed clinicians and does not sell or endorse the food or supplement reviewed on this page.